Cargando…
Polyisoprenylated methylated protein methyl esterase as a putative drug target for androgen-insensitive prostate cancer
Prostate cancer (CaP) is the most frequently diagnosed cancer in US men, with an estimated 236,590 new cases and 29,720 deaths in 2013. There exists the need to identify biomarkers/therapeutic targets for the early/companion diagnosis and development of novel therapies against the recalcitrant disea...
Autores principales: | Poku, Rosemary A, Amissah, Felix, Duverna, Randolph, Aguilar, Byron J, Kiros, Gebre-Egziabher, Lamango, Nazarius S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154947/ https://www.ncbi.nlm.nih.gov/pubmed/25228915 http://dx.doi.org/10.3332/ecancer.2014.459 |
Ejemplares similares
-
Polyisoprenylated Methylated Protein Methyl Esterase Is Both Sensitive to Curcumin and Overexpressed in Colorectal Cancer: Implications for Chemoprevention and Treatment
por: Amissah, Felix, et al.
Publicado: (2013) -
The antiangiogenic effects of polyisoprenylated cysteinyl amide inhibitors in HUVEC, chick embryo and zebrafish is dependent on the polyisoprenyl moiety
por: Nkembo, Augustine T., et al.
Publicado: (2016) -
Polyisoprenylated cysteinyl amide inhibitors disrupt actin cytoskeleton organization, induce cell rounding and block migration of non-small cell lung cancer
por: Ntantie, Elizabeth, et al.
Publicado: (2017) -
Polyisoprenylated cysteinyl amide inhibitors deplete singly polyisoprenylated monomeric G-proteins in lung and breast cancer cell lines
por: Tawfeeq, Nada, et al.
Publicado: (2023) -
Synthetic Optimization and MAPK Pathway Activation Anticancer Mechanism of Polyisoprenylated Cysteinyl Amide Inhibitors
por: Tawfeeq, Nada, et al.
Publicado: (2021)